The First Step To Navigating Your Combination Product's Regulatory Pathway: PMOA
Source: Phillips-Medisize
To avoid unnecessary delays and gain speed to market through ‘right the first time’ regulatory submissions for a combination product, sponsor companies must understand the various pathways for which a combination product can travel. Each of these pathways is based on correctly determining a key piece of information – the product’s primary mode of action (PMOA).
access the White Paper!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Phillips-Medisize
This website uses cookies to ensure you get the best experience on our website. Learn more